European Researchers Urge H5N1 Caution

A group of scientists has called on the European Commission to evaluate the risks and benefits of research that could make deadly viruses more transmissible.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Colorized transmission electron micrograph of Avian influenza A H5N1 viruses (seen in gold)WIKIMEDIA, CDCMore than 50 researchers have signed a letter to European Commission (EC) president José Manuel Barroso urging the body to hold a conference to discuss the wisdom of continuing with so-called “gain-of-function” studies, in which viruses are mutated to become more transmissible between mammals. “Gain-of-function research into highly pathogenic microbes with pandemic potential has global implications for public health,” Columbia University infectious disease researcher and letter signatory Ian Lipkin told Nature. “We are not seeking to shut down all gain-of-function research, but asking that stakeholders meet to establish guidelines for doing it.”

The work that sparked the debate around gain-of-function studies, and prompted the December 18 letter, was that of virologist Ron Fouchier of Erasmus Medical Center in Rotterdam, the Netherlands. In 2011, Fouchier struggled to find a journal that would publish his research on mutating the deadly H5N1 strain of the avian flu virus so that it could be transmitted via airborne particles between ferrets, something that was not possible before his genetic manipulations.

Fouchier’s struggles, which included the Dutch government using export regulations to bar him from publishing his results, compelled the European Society for Virology (ESV) to write its own letter to the EC in October. That letter expressed concern that the Dutch government’s tactics were inappropriate and threatened to set a precedent that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies